Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence.

Usonis V, Ivaskeviciene I, Desselberger U, Rodrigo C; Pediatric ROTavirus European CommiTtee (PROTECT).

Vaccine. 2012 Jun 29;30(31):4596-605. doi: 10.1016/j.vaccine.2012.04.097. Epub 2012 May 10. Review.

PMID:
22579864
2.

G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population.

Antunes H, Afonso A, Iturriza M, Martinho I, Ribeiro C, Rocha S, Magalhães C, Carvalho L, Branca F, Gray J.

J Clin Virol. 2009 May;45(1):76-8. doi: 10.1016/j.jcv.2009.03.010. Epub 2009 Apr 17.

PMID:
19375980
3.

Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.

Räsänen S, Lappalainen S, Halkosalo A, Salminen M, Vesikari T.

Scand J Infect Dis. 2011 Jan;43(1):58-63. doi: 10.3109/00365548.2010.508462. Epub 2010 Aug 31.

PMID:
20807022
4.

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network.

Iturriza-Gómara M, Dallman T, Bányai K, Böttiger B, Buesa J, Diedrich S, Fiore L, Johansen K, Koopmans M, Korsun N, Koukou D, Kroneman A, László B, Lappalainen M, Maunula L, Marques AM, Matthijnssens J, Midgley S, Mladenova Z, Nawaz S, Poljsak-Prijatelj M, Pothier P, Ruggeri FM, Sanchez-Fauquier A, Steyer A, Sidaraviciute-Ivaskeviciene I, Syriopoulou V, Tran AN, Usonis V, VAN Ranst M, DE Rougemont A, Gray J.

Epidemiol Infect. 2011 Jun;139(6):895-909. doi: 10.1017/S0950268810001810. Epub 2010 Aug 16.

PMID:
20707941
5.

Rotavirus A genotype P[4]G2: genetic diversity and reassortment events among strains circulating in Brazil between 2005 and 2009.

Gómez MM, de Mendonça MC, Volotão Ede M, Tort LF, da Silva MF, Cristina J, Leite JP.

J Med Virol. 2011 Jun;83(6):1093-106. doi: 10.1002/jmv.22071.

PMID:
21503926
6.

Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?

Matthijnssens J, Nakagomi O, Kirkwood CD, Ciarlet M, Desselberger U, Van Ranst M.

Expert Rev Vaccines. 2012 Nov;11(11):1347-54. doi: 10.1586/erv.12.105. Review.

PMID:
23249234
7.

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA.

Hum Vaccin. 2011 Jul;7(7):734-48. doi: 10.4161/hv.7.7.15511. Epub 2011 Jul 1. Review.

PMID:
21734466
8.

Rotavirus types in Europe and their significance for vaccination.

Desselberger U, Wolleswinkel-van den Bosch J, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S30-41. Review.

PMID:
16397427
9.

The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.

Zlamy M, Kofler S, Orth D, Würzner R, Heinz-Erian P, Streng A, Prelog M.

BMC Infect Dis. 2013 Mar 1;13:112. doi: 10.1186/1471-2334-13-112.

10.

A mathematical model of the indirect effects of rotavirus vaccination.

Van Effelterre T, Soriano-Gabarró M, Debrus S, Claire Newbern E, Gray J.

Epidemiol Infect. 2010 Jun;138(6):884-97. doi: 10.1017/S0950268809991245. Epub 2009 Dec 23.

PMID:
20028612
11.

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.

Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H.

Vaccine. 2011 Mar 24;29(15):2791-6. doi: 10.1016/j.vaccine.2011.01.104. Epub 2011 Feb 12.

PMID:
21320539
12.

The evolving epidemiology of rotavirus gastroenteritis in central Portugal with modest vaccine coverage.

Rodrigues F, Iturriza-Gómara M, Marlow R, Gray J, Nawaz S, Januário L, Finn A.

J Clin Virol. 2013 Feb;56(2):129-34. doi: 10.1016/j.jcv.2012.10.016. Epub 2012 Dec 11.

PMID:
23238239
13.

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.

Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434.

PMID:
19935446
14.

Emergence of human rotavirus genotype G9 in metropolitan Detroit between 2007 and 2009.

Abdel-Haq N, Amjad M, McGrath E, Chearskul P, Amer A, Salimnia H, Asmar BI.

J Med Microbiol. 2011 Jun;60(Pt 6):761-7. doi: 10.1099/jmm.0.026807-0. Epub 2011 Mar 3.

PMID:
21372186
15.

Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination.

Hahné S, Hooiveld M, Vennema H, van Ginkel A, de Melker H, Wallinga J, van Pelt W, Bruijning-Verhagen P.

Euro Surveill. 2014 Oct 30;19(43). pii: 20945.

16.

Real-world impact of rotavirus vaccination.

Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5. doi: 10.1097/INF.0b013e3181fefa1f. Review. No abstract available.

PMID:
21183833
17.

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease.

Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z, Giaquinto C, Grimprel E.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S12-21. Review.

PMID:
16397425
18.

Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.

Plosker GL.

Pharmacoeconomics. 2011 May;29(5):439-54. doi: 10.2165/11207130-000000000-00000. Review.

PMID:
21504245
19.

In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13.

Hungerford D, Vivancos R; EuroRotaNet network members, Read JM, Pitzer VE, Cunliffe N, French N, Iturriza-Gómara M.

Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30106.

20.

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.

Tilson L, Jit M, Schmitz S, Walsh C, Garvey P, McKeown P, Barry M.

Vaccine. 2011 Oct 6;29(43):7463-73. doi: 10.1016/j.vaccine.2011.07.056. Epub 2011 Aug 5.

PMID:
21821085

Supplemental Content

Support Center